News

Exciting Announcement: Oxford Lane Capital Corp. Offering Notes

Exciting Announcement: Oxford Lane Capital Corp. Offering Notes

Oxford Lane Capital Corp. Launches New Notes Offering

Oxford Lane Capital Corp. (Nasdaq: OXLC), a prominent name in the investment sector, has recently announced an exciting new phase in its financial strategies. The company has commenced a registered public offering of notes, aimed at enhancing its capital structure and investment potential. This significant move comes as part of their strategy to further expand their investment portfolio and provide value to their investors.

Details of the Offering

The specific public offering price and terms of the notes are yet to be established, with negotiations currently underway between Oxford Lane Capital Corp. and their chosen underwriters. An appealing aspect of this offering is that the company plans to provide the underwriters with a 30-day option to purchase additional notes. This ensures that they can accommodate any over-allotments that might arise during the offering period.

Market Listing Prospects

Investors can look forward to the notes being listed on the NASDAQ Global Select Market. The intentions are for them to begin trading within 30 days of their initial issue date, which is an encouraging aspect for potential investors. This anticipated liquidity could attract a diverse range of investment strategies.

Utilization of Proceeds

Oxford Lane Capital Corp. has plans for utilizing the net proceeds from this offering strategically. The funds will primarily serve to acquire new investments in line with the company's established investment goals while also providing necessary working capital. This objective underscores the company’s commitment to maintaining a robust investment strategy that aligns with market demands.

Management Team

In the management of this offering, Lucid Capital Markets, LLC and Piper Sandler & Co. are stepping in as the joint book-running managers, showcasing the seriousness and professionalism behind the offering. Additionally, notable firms such as Clear Street LLC, InspereX LLC, Janney Montgomery Scott LLC, and William Blair & Company, L.L.C. are acting as lead managers, emphasizing the collaborative effort to boost this financial endeavor.

About Oxford Lane Capital Corp.

Oxford Lane Capital Corp. stands out as a publicly-traded registered closed-end management investment company, specializing in the investment of debt and equity tranches of collateralized loan obligations (CLOs). Their expertise extends to warehouse facilities too, which serve as financing structures that gather loans aimed at forming the backbone of CLO vehicles. This intricate understanding of the investment landscape has allowed the company to thrive in providing strong returns for its investors.

Conclusion

Oxford Lane Capital Corp.’s recent notes offering marks a strategic effort to continue enhancing its investment capabilities in a dynamic market. As they navigate through this process, prospective and current investors should keep a keen eye on developments, given how pivotal this could be for the company’s future endeavors.

Frequently Asked Questions

What is the purpose of the notes offering by Oxford Lane Capital Corp.?

The offering aims to raise capital for acquiring new investments and general working capital purposes.

Who are the underwriters for the notes offering?

Lucid Capital Markets, LLC and Piper Sandler & Co. are the joint book-running managers.

Where will the notes be traded?

The notes are expected to be listed on the NASDAQ Global Select Market.

How will the proceeds from the offering be used?

The proceeds will be used to support the company's investment strategies and contribute to working capital.

What type of company is Oxford Lane Capital Corp.?

Oxford Lane Capital Corp. is a publicly-traded registered closed-end management investment company that primarily invests in CLOs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Plus Therapeutics Advances with REYOBIQ™ in Clinical Trial Results

Updated Category News Views 142

Plus Therapeutics Showcases Clinical Advances in REYOBIQ™ Houston-based Plus Therapeutics, Inc. (NASDAQ: PSTV) recently presented its promising results from the ReSPECT-LM clinical trial, specifically focusing on the treatment of patients with leptomeningeal metastases (LM). This presentation was made by the trial's principal investigator during the notable SNO/ASCO CNS...

Continue Reading
Investors Eye Domo's Earnings Report with Anticipation

Updated Category News Views 95

Domo Earnings Report Overview Domo (NASDAQ: DOMO) is preparing to announce its quarterly earnings, and anticipation is building among investors. This release is particularly significant as the market eagerly awaits insights into the company’s fiscal health and future guidance. What Analysts Expect Analysts predict that Domo will report an earnings per share (EPS) of...

Continue Reading
Analyzing Haleon PLC's Recent Market Performance Trends

Updated Category News Views 106

Understanding Recent Trends in Haleon PLC Stock Haleon PLC (NYSE: HLN) has recently seen a notable increase in its short interest, which has grown by 10.34% since the last report. Currently, there are approximately 14.34 million shares sold short, comprising around 0.32% of all the available shares for trading. The Significance of Short Interest But what does this short...

Continue Reading
Energy Price Trends Amid Political Promises for 2024

Updated Category News Views 202

Examining the Effects of Political Promises on Energy Prices As the upcoming election approaches, politicians are making strong promises focused on energy. Former President Donald Trump is pushing for a "drill, baby, drill" strategy to help reduce energy prices, while Vice President Kamala Harris is prioritizing her commitment to fracking. Looking Ahead: Energy Trends...

Continue Reading
Rob Conti Elevated to CIO of First Watch Restaurant Group

Updated Category News Views 195

First Watch Appoints Rob Conti as Chief Information Officer First Watch Restaurant Group, Inc. (NASDAQ: FWRG), a prominent name in daytime dining, has made a notable leadership change by promoting Rob Conti to the position of Chief Information Officer. Since joining the company in 2019, Conti has been a vital part of the team, having previously held the role of Senior...

Continue Reading